A high-fat diet modulates iron metabolism but does not promote liver fibrosis in hemochromatotic hjv-/- mice

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 308, Issue 4, 2015, Pages G251-G261

  Padda, Ranjit Singh ^a   Gkouvatsos, Konstantinos ^a   Guido, Maria ^b   Mui, Jeannie ^c   Vali, Hojatollah ^c   Pantopoulos, Kostas ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF PADOVA   (Italy)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Hemochromatosis; Iron overload; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CARBONYL IRON; CHOLESTEROL; FAT DROPLET; GLUCOSE; HEPCIDIN; IRON; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRIACYLGLYCEROL; ACTIN; ALPHA-SMOOTH MUSCLE ACTIN, MOUSE; GLUCOSE BLOOD LEVEL; HFE2 PROTEIN, MOUSE; IRON DERIVATIVE; MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; INTRAABDOMINAL FAT; IRON BLOOD LEVEL; IRON METABOLISM; IRON OVERLOAD; LIPID DIET; LIPID METABOLISM; LIVER FIBROSIS; LIVER LEVEL; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; C57BL MOUSE; COMPLICATION; DEFICIENCY; DISEASE COURSE; DISEASE MODEL; DRUG EFFECTS; FATTY LIVER; GENETICS; GENOTYPE; HEMOCHROMATOSIS; KNOCKOUT MOUSE; LIVER; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY; PHENOTYPE; RISK FACTOR; TIME; WEIGHT GAIN;

ACTINS; ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FATTY LIVER; GENOTYPE; HEMOCHROMATOSIS; HEPCIDINS; IRON; IRON COMPOUNDS; LIVER; LIVER CIRRHOSIS; MALE; MEMBRANE PROTEINS; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; RISK FACTORS; TIME FACTORS; WEIGHT GAIN;

EID: 84927169986     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00137.2014     Document Type: Article

References (40)

1. Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, Samad TA, Campagna JA, Chung RT, Schneyer AL, Woolf CJ, Andrews NC, Lin HY. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 38: 531-539, 2006.
2. Beutler E. The HFE Cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary hemochromatosis. Blood 101: 3347-3350, 2003.
3. Chung J, Kim MS, Han SN. Diet-induced obesity leads to decreased hepatic iron storage in mice. Nutr Res 31: 915-921, 2011.
4. Corradini E, Pietrangelo A. Iron and steatohepatitis. J Gastroenterol Hepatol 27, Suppl 2: 42-46, 2012.
5. Daba A, Gkouvatsos K, Sebastiani G, Pantopoulos K. Differences in activation of mouse hepcidin by dietary iron and parenterally administered iron dextran: compartmentalization is critical for iron sensing. J Mol Med (Berl) 91: 95-102, 2013.
6. Delima RD, Chua AC, Tirnitz-Parker JE, Gan EK, Croft KD, Graham RM, Olynyk JK, Trinder D. Disruption of HFE and TFR2 causes iron-induced liver injury in mice. Hepatology 56: 585-593, 2012.
7. Diez JJ, Iglesias P. The role of the novel adipocyte-derived protein adiponectin in human disease: an update. Mini Rev Med Chem 10: 856-869, 2010.
8. Dongiovanni P, Ruscica M, Rametta R, Recalcati S, Steffani L, Gatti S, Girelli D, Cairo G, Magni P, Fargion S, Valenti L. Dietary iron overload induces visceral adipose tissue insulin resistance. Am J Pathol 182: 2254-2263, 2013.
9. Fleming RE, Feng Q, Britton RS. Knockout mouse models of iron homeostasis. Annu Rev Nutr 31: 117-137, 2011.
10. Fleming RE, Ponka P. Iron overload in human disease. N Engl J Med 366: 348-359, 2012.
11. Gabrielsen JS, Gao Y, Simcox JA, Huang J, Thorup D, Jones D, Cooksey RC, Gabrielsen D, Adams TD, Hunt SC, Hopkins PN, Cefalu WT, McClain DA. Adipocyte iron regulates adiponectin and insulin sensitivity. J Clin Invest 122: 3529-3540, 2012.
12. Galaris D, Pantopoulos K. Oxidative stress and iron homeostasis: mechanistic and health aspects. Crit Rev Clin Lab Sci 45: 1-23, 2008.
13. Ganz T. Systemic iron homeostasis. Physiol Rev 93: 1721-1741, 2013.
14. George DK, Goldwurm S, MacDonald GA, Cowley LL, Walker NI, Ward PJ, Jazwinska EC, Powell LW. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 114: 311-318, 1998.
15. Gkouvatsos K, Fillebeen C, Daba A, Wagner J, Sebastiani G, Pantopoulos K. Iron-dependent regulation of hepcidin in Hjv—/— mice: Evidence that hemojuvelin is dispensable for sensing body iron levels. PLoS ONE 9: e85530, 2014.
16. Graham RM, Chua AC, Carter KW, Delima RD, Johnstone D, Herbison CE, Firth MJ, O’Leary R, Milward EA, Olynyk JK, Trinder D. Hepatic iron loading in mice increases cholesterol biosynthesis. Hepatology 52: 462–471, 2010.
17. Huang FW, Pinkus JL, Pinkus GS, Fleming MD, Andrews NC. A mouse model of juvenile hemochromatosis. J Clin Invest 115: 2187-2191, 2005.
18. Huang J, Gabrielsen JS, Cooksey RC, Luo B, Boros LG, Jones DL, Jouihan HA, Soesanto Y, Knecht L, Hazel MW, Kushner JP, McClain DA. Increased glucose disposal and AMP-dependent kinase signaling in a mouse model of hemochromatosis. J Biol Chem 282: 37501-37507, 2007.
19. Imeryuz N, Tahan V, Sonsuz A, Eren F, Uraz S, Yuksel M, Akpulat S, Ozcelik D, Haklar G, Celikel C, Avsar E, Tozun N. Iron preloading aggravates nutritional steatohepatitis in rats by increasing apoptotic cell death. J Hepatol 47: 851-859, 2007.
20. Kirsch R, Sijtsema HP, Tlali M, Marais AD, Hall Pde L. Effects of iron overload in a rat nutritional model of non-alcoholic fatty liver disease. Liver Int 26: 1258-1267, 2006.
21. Li Z, Soloski MJ, Diehl AM. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology 42: 880-885, 2005.
22. Meli R, Mattace Raso G, Irace C, Simeoli R, Di Pascale A, Paciello O, Pagano TB, Calignano A, Colonna A, Santamaria R. High Fat Diet Induces Liver Steatosis and Early Dysregulation of Iron Metabolism in Rats. PLoS ONE 8: e66570, 2013.
23. Nelson JE, Bhattacharya R, Lindor KD, Chalasani N, Raaka S, Heathcote EJ, Miskovsky E, Shaffer E, Rulyak SJ, Kowdley KV. HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis. Hepatology 46: 723-729, 2007.
24. Nelson JE, Klintworth H, Kowdley KV. Iron metabolism in Nonalcoholic Fatty Liver Disease. Curr Gastroenterol Rep 14: 8-16, 2012.
25. Nelson JE, Wilson L, Brunt EM, Yeh MM, Kleiner DE, Unalp-Arida A, Kowdley KV and Nonalcoholic Steatohepatitis Clinical Research N. Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease. Hepatology 53: 448-457, 2011.
26. Otogawa K, Kinoshita K, Fujii H, Sakabe M, Shiga R, Nakatani K, Ikeda K, Nakajima Y, Ikura Y, Ueda M, Arakawa T, Hato F, Kawada N. Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: implications for the pathogenesis of human nonalcoholic steatohepatitis. Am J Pathol 170: 967-980, 2007.
27. Pantopoulos K. Function of the hemochromatosis protein HFE: Lessons from animal models. World J Gastroenterol 14: 6893-6901, 2008.
28. Papanikolaou G, Samuels ME, Ludwig EH, MacDonald ML, Franchini PL, Dube MP, Andres L, MacFarlane J, Sakellaropoulos N, Politou M, Nemeth E, Thompson J, Risler JK, Zaborowska C, Ba-bakaiff R, Radomski CC, Pape TD, Davidas O, Christakis J, Brissot P, Lockitch G, Ganz T, Hayden MR, Goldberg YP. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 36: 77-82, 2004.
29. Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, treatment. Gastroenterology 139: 393–408, 2010.
30. Powell EE, Ali A, Clouston AD, Dixon JL, Lincoln DJ, Purdie DM, Fletcher LM, Powell LW, Jonsson JR. Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology 129: 1937-1943, 2005.
31. Ramm GA, Ruddell RG. Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis. Semin Liver Dis 25: 433-449, 2005.
32. Rohrlich PS, Fazilleau N, Ginhoux F, Firat H, Michel F, Cochet M, Laham N, Roth MP, Pascolo S, Nato F, Coppin H, Charneau P, Danos O, Acuto O, Ehrlich R, Kanellopoulos J, Lemonnier FA. Direct recognition by alphabeta cytolytic T cells of Hfe, a MHC class Ib molecule without antigen-presenting function. Proc Natl Acad Sci USA 102: 12855-12860, 2005.
33. Sebastiani G, Gkouvatsos K, Maffettone C, Busatto G, Guido M, Pantopoulos K. Accelerated CCl4-induced liver fibrosis in Hjv—/— mice, associated with an oxidative burst and precocious profibrogenic gene expression. PLoS ONE 6: e25138, 2011.
34. Sebastiani G, Pantopoulos K. Disorders associated with systemic or local iron overload: from pathophysiology to clinical practice. Metallomics 3: 971-986, 2011.
35. Shi Z, Wakil AE, Rockey DC. Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci USA 94: 10663-10668, 1997.
36. Sonnweber T, Ress C, Nairz M, Theurl I, Schroll A, Murphy AT, Wroblewski V, Witcher DR, Moser P, Ebenbichler CF, Kaser S, Weiss G. High-fat diet causes iron deficiency via hepcidin-independent reduction of duodenal iron absorption. J Nutr Biochem 23: 1600-1608, 2012.
37. Sorrentino P, D’Angelo S, Ferbo U, Micheli P, Bracigliano A, Vecchione R. Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis. J Hepatol 50: 351-357, 2009.
38. Tan TC, Crawford DH, Jaskowski LA, Murphy TM, Heritage ML, Subramaniam VN, Clouston AD, Anderson GJ, Fletcher LM. Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis. Am J Physiol Gastrointest Liver Physiol 301: G865–G876, 2011. 39.
39. Valenti L, Fracanzani AL, Bugianesi E, Dongiovanni P, Galmozzi E, Vanni E, Canavesi E, Lattuada E, Roviaro G, Marchesini G, Fargion S. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology 138: 905–912, 2010. 40.
40. Wang J, Pantopoulos K. Regulation of cellular iron metabolism. Biochem J 434: 365–381, 2011.